Focused.
Entrepreneurial.
Disciplined.

welcome to Merus Labs

Merus Labs is an international specialty pharmaceutical company focused on acquiring and optimizing legacy and growth products. The Company leverages its expertise and scalable platform in Europe, Canada and select other markets to deliver value. Merus Labs is listed on the Toronto Stock Exchange (MSL) and NASDAQ (MSLI).

Investor Presentation
Corporate Video
More on Merus Labs

Latest News

Merus Labs Receives NASDAQ Notice Regarding Minimum Bid Price Requirements.

Merus Labs Announces Reduced Interest Rate on Senior Secured Debt and Reduced Leverage

Merus Labs Reports Fiscal Q3 2016 Results.

Merus Labs Quick Facts

PRODUCTS
COUNTRIES
+
PATIENTS